91820-96-1 Usage
Uses
Used in Pharmaceutical Research and Development:
1-Benzyl-piperidine-3-carbonitrile is utilized as a key intermediate in the synthesis of various biologically active molecules, contributing to the advancement of new drug candidates. Its unique structure allows for the creation of compounds with diverse therapeutic potentials, addressing a wide range of medical conditions.
Used in Medicinal Chemistry:
As a building block in medicinal chemistry, 1-Benzyl-piperidine-3-carbonitrile is employed for the design and synthesis of novel compounds with potential pharmaceutical applications. Its incorporation into molecular structures can enhance the pharmacological properties of these compounds, such as their efficacy, selectivity, and safety profiles.
Used in Regulatory and Law Enforcement:
1-Benzyl-piperidine-3-carbonitrile is recognized as a potential intermediate in the synthesis of certain psychoactive substances. As such, it is used by regulatory and law enforcement agencies to monitor and control its availability and use, ensuring that it is not diverted for illicit purposes and maintaining the integrity of the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 91820-96-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,8,2 and 0 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 91820-96:
(7*9)+(6*1)+(5*8)+(4*2)+(3*0)+(2*9)+(1*6)=141
141 % 10 = 1
So 91820-96-1 is a valid CAS Registry Number.
91820-96-1Relevant academic research and scientific papers
SUBSTITUTED 3- AND 4- AMINOMETHYLPIPERIDINES FOR USE AS BETA-SECRETASE IN THE TREATMENT OF ALZHEIMER’S DISEASE
-
Page/Page column 23; 44; 46, (2008/06/13)
The invention relates to novel compounds, which are substituted chiral or achiral derivatives of 3- or 4- aminomethylpiperidine of the general formula (I). The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more compounds of general formula (I) and especially their use as inhibitors of beta-secretases for the treatment of Alzheimer’s disease.
